AbbVie Inc. (NYSE:ABBV)

Short Sellers Back Way Off Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Why AbbVie Won Big in Q3, and Can Keep Winning

When AbbVie Inc. (NYSE: ABBV) released its most recent quarterly results before the markets opened on Friday, the company posted $1.41 in earnings per share (EPS) and $7.0 billion in ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Celgene, Gilead, Biogen and More Major Biopharmas Reporting This Week

Third-quarter earnings reporting season is now well under way. So far, things are looking good. The health care sector has yet to see any significant earnings representation, but that will ...
Read Full Story »

4 Large Cap Pharmaceutical Stocks That Could Post Big Earnings

With a market that has become as expensive as this one, there is one key driver that can keep things going, and that’s positive earnings or guidance for the next ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Amazon, Facebook, Johnson & Johnson, Schlumberger, Visa, Walmart and More

Stocks were indicated to open marginally lower on Wednesday morning, but that is after the Dow hit new all-time highs on Tuesday and has come within 170 points of hitting ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

Stocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one trend that has been proven time after time in this eight-year bull market ...
Read Full Story »

5 Stocks to Buy That Are Much Cheaper Than the S&P 500

The higher the markets have gone, the more nerve-wracking equity investing has become. With the venerable S&P 500 index sitting at all-time valuation highs, it seems as though everything is ...
Read Full Story »

AbbVie and Amgen Reach Global Resolution of Humira

AbbVie Inc. (NYSE: ABBV) shares made a handy gain on Thursday after it was announced that the company resolved its Humira patent disputes with Amgen Inc. (NASDAQ: AMGN). What’s important ...
Read Full Story »

Major Pharma Short Interest Piles On

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Albermarle, Blue Apron, Box, Dish Network, GM, Transocean, Under Armour and More

Stocks were looking for direction on Monday morning after hitting all-time highs last week. The primary trend that has dominated this eight-year bull market is that investors keep finding new ...
Read Full Story »

Friday’s Top Analyst Upgrades and Downgrades: AbbVie, Bristol-Myers, Eli Lilly, First Solar, Generac, Oracle, Sirius XM, Southwest, Wendy’s and More

Stocks were looking for direction on Friday morning, after the Dow and S&P 500 broke to new all-time highs this week. The Dow now has hit close to 50 new highs since ...
Read Full Story »

Major Pharma Short Interest Surges

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Thursday’s Biggest Winners and Losers in the S&P 500

September 7, 2017: The S&P 500 closed flat at 2,465.16. The DJIA closed down 0.1% at 21,786.29. Separately, the Nasdaq closed relatively flat at 6,397.87. Thursday was a mixed day for ...
Read Full Story »